Traduction de «bones has been growing due to improved compliance and use » (Néerlandais → Français) :

Zometa (USD 701 million, +10% lc), an intravenous bisphosphonate therapy for patients with cancer that has spread to the bones, has been growing due to improved compliance and use in existing indications.
Zometa (USD 701 millions, +10% en m. l.), bisphosphonate intraveineux contre les métastases osseuses du cancer, a continué de progresser grâce à une amélioration de sa conformité aux indications existantes.

Zometa (USD 1.1 billion, +9% lc), an intravenous bisphosphonate therapy for patients with cancer that has spread to bones, is growing due to improved compliance and use in existing indications.
Zometa (USD 1,1 milliard, +9% en m. l.), bisphosphonate intraveineux contre les métastases osseuses du cancer, progresse grâce à une amélioration de sa conformité aux indications existantes dans lesquelles il est toujours plus utilisé.

Zometa (USD 1.5 billion, +9% lc), an intravenous bisphosphonate therapy for patients with certain types of cancer that has spread to bones, is growing due to improved compliance and use in existing indications.
Zometa (USD 1,5 milliard, +9% en m. l.), traitement au bisphosphonate intraveineux contre les métastases osseuses du cancer, progresse grâce à une amélioration de sa conformité et de son utilisation dans les indications existantes.

Zometa (USD 375 million, +5% cc) expansion has come from improved compliance and use of this intravenous bisphosphonate therapy in patients with certain types of cancer that has spread to bones, particularly in key European markets.
Zometa (USD 375 millions, +5% tcc), traitement au bisphosphonate intraveineux contre les métastases osseuses du cancer, progresse grâce à une amélioration de sa conformité et de son utilisation, particulièrement dans les principaux marchés européens.

Zometa (USD 378 million, +6% cc) expansion has come from improved compliance and increased use of this intravenous bisphosphonate therapy in patients with certain types of cancer which have spread to the bone.
Zometa (USD 378 millions, +6% tcc), progresse grâce à une amélioration de sa conformité et à une augmentation de l’utilisation de ce traitement intraveineux au bisphosphonate contre certains types de cancers provoquant des métastases osseuses.